Oneness Biotech (Taiwan) Today
| 4743 Stock | TWD 106.50 3.00 2.90% |
Performance0 of 100
| Odds Of DistressLess than 35
|
Oneness Biotech is selling for under 106.50 as of the 26th of November 2024; that is 2.90 percent increase since the beginning of the trading day. The stock's lowest day price was 104.0. Oneness Biotech has about a 35 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Oneness Biotech Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of December 2022 and ending today, the 26th of November 2024. Click here to learn more.
Moving together with Oneness Stock
Moving against Oneness Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Oneness Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Oneness Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Oneness Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Oneness Biotech Co (4743) is traded on Taiwan OTC Exchange in Taiwan and employs 20 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 105.11 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Oneness Biotech's market, we take the total number of its shares issued and multiply it by Oneness Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Oneness Biotech operates under Healthcare sector and is part of Biotechnology industry. The entity has 387.86 M outstanding shares.
Oneness Biotech generates negative cash flow from operations
Check Oneness Biotech Probability Of Bankruptcy
Ownership AllocationOneness Biotech owns a total of 387.86 Million outstanding shares. Oneness Biotech has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Oneness Ownership Details
Oneness Biotech Risk Profiles
Although Oneness Biotech's alpha and beta are two of the key measurements used to evaluate Oneness Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.73 | |||
| Standard Deviation | 2.34 | |||
| Variance | 5.49 | |||
| Risk Adjusted Performance | (0.18) |
Oneness Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Oneness Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Oneness Biotech Corporate Management
Elected by the shareholders, the Oneness Biotech's board of directors comprises two types of representatives: Oneness Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Oneness. The board's role is to monitor Oneness Biotech's management team and ensure that shareholders' interests are well served. Oneness Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Oneness Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| NienYi Chen | Deputy Division | Profile | |
| MP MD | VP Affairs | Profile | |
| WenTzu Hsiao | Acting Department | Profile | |
| KungMing Lu | Director Center | Profile | |
| ChihHui Cheng | GM Governance | Profile | |
| Debbie Fang | Mang Department | Profile | |
| JuiChing Chen | Director Department | Profile |
Additional Tools for Oneness Stock Analysis
When running Oneness Biotech's price analysis, check to measure Oneness Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oneness Biotech is operating at the current time. Most of Oneness Biotech's value examination focuses on studying past and present price action to predict the probability of Oneness Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oneness Biotech's price. Additionally, you may evaluate how the addition of Oneness Biotech to your portfolios can decrease your overall portfolio volatility.